• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Apollomics Inc. - Class A Ordinary Shares (NQ:APLM)

    13.97 +2.36 (+20.33%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 31, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Apollomics Inc. - Class A Ordinary Shares

    < Previous 1 2 3 4 5 Next >
    12 Health Care Stocks Moving In Tuesday's Intraday Session
     
    Via Benzinga
    Apollomics Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
    Apollomics has an initial 180-day period through July 15, 2024 to regain compliance with Minimum Bid Price Requirement 
    From Apollomics Inc.
    Via GlobeNewswire
    Apollomics to Participate in a Fireside Chat at the B. Riley Securities’ 2024 Virtual Oncology Conference
    From Apollomics Inc.
    Via GlobeNewswire
    Why Is Cancer Firm Apollomics Stock Trading Higher Today?
    Apollomics Inc's (NASDAQ: APLM) partner in China, Avistone Biotechnology Co. 
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
    We're starting out the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday morning! 
    Via InvestorPlace
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
     
    Via Benzinga
    Week In Review: 2024 Kicks Off With Three Deals Worth A Total Of $4 Billion
    Suzhou Ribo Life Science formed a collaboration with Boehringer Ingelheim in a deal that could be worth up to $2 billion. Additionally, Allorion Therapeutics has out-licensed global rights (ex-China)... 
    Via Talk Markets
    Apollomics Completes Enrollment in Phase 3 Bridging Study of Uproleselan in Chinese Patients with Relapsed/Refractory Acute Myeloid Leukemia
    From Apollomics Inc.
    Via GlobeNewswire
    Apollomics to Present at the 2024 Biotech Showcase
    From Apollomics Inc.
    Via GlobeNewswire
    Apollomics Presents Interim Data from Two Ongoing Phase 2 Clinical Trials with Vebreltinib in NSCLC Patients with MetExon14 Skipping Mutation
    From Apollomics Inc.
    Via GlobeNewswire
    Why Salesforce Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket
    Shares of Salesforce, Inc. 
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
    It's time for a breakdown of the biggest pre-market stock movers as we check out all of the hottest news on Thursday morning! 
    Via InvestorPlace
    Apollomics to Participate in a Fireside Chat at the H.C. Wainwright 4th Annual Precision Oncology Virtual Conference
    From Apollomics Inc.
    Via GlobeNewswire
    Apollomics Announces Presentation of Vebreltinib Data at the 2023 IASLC North America Conference on Lung Cancer (NACLC)
    From Apollomics Inc.
    Via GlobeNewswire
    Why Anavex Life Sciences Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Shares of Anavex Life Sciences Corp. (NASDAQ: AVXL) moved lower during Monday’s session after the company reported fourth-quarter financial results. 
    Via Benzinga
    Why UP Fintech Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
    Shares of UP Fintech Holding Limited (NASDAQ: TIGR) surged in pre-market trading after the company results for the third quarter. 
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
     
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
    It's time to start the week with a breakdown of the biggest pre-market stock movers that are worth watching on Monday morning! 
    Via InvestorPlace
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
     
    Via Benzinga
    Week In Review: Legend Partners DLL3 CAR-T Candidate With Novartis In $1.2 Billion Deal
    Legend Biotech partnered its DLL3 CAR-T candidates to Novartis in a $1.2 billion agreement, with $100 million offered upfront. Novartis will own worldwide rights to develop, manufacture, and... 
    Via Talk Markets
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
    It's time to start the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday morning! 
    Via InvestorPlace
    Why Children's Place Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Shares of The Children's Place, Inc. (NASDAQ: PLCE) moved lower during Thursday’s session following weak quarterly earnings. 
    Via Benzinga
    US Stocks Down; Jobless Claims Rise To 231,000
    U.S. stocks traded lower this morning, following the release of jobless claims data. Following the market opening Thursday, the Dow traded down 0.23% to 34,911.22 while the NASDAQ fell 0.19% to... 
    Via Benzinga
    Topics Stocks
    Apollomics Announces the First Approval of Vebreltinib for MET Exon 14 Skip Non-Small Cell Lung Cancer
    From Apollomics Inc.
    Via GlobeNewswire
    Apollomics Announces Two New Cohorts in Global Phase 2 SPARTA Study of Vebreltinib in Non-Small Cell Lung Cancer and Other Solid Tumors with MET Dysregulation
    From Apollomics Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Friday's Intraday Session
     
    Via Benzinga
    What's Going On With Apollomics Inc Stock?
    Apollomics Inc. (NASDAQ:) shares are volatile Friday, and the stock has dropped by more than 75% over the last month. Here's a look at what's going on:  What To Know: 
    Via Benzinga
    Why Barnes Group Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Gainers Apollomics, Inc. (NASDAQ: APLM) shares surged 88.4% to $1.07 stoma multiforme with PTPRZ-MET fusion. 
    Via Benzinga
    Nasdaq Jumps 100 Points; Amazon Posts Upbeat Earnings
    U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining more than 100 points on Friday. Following the market opening Friday, the Dow traded down 0.12% to 32,744.42 while the... 
    Via Benzinga
    Topics Stocks
    12 Health Care Stocks Moving In Friday's Pre-Market Session
     
    Via Benzinga
    < Previous 1 2 3 4 5 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.